Wildt M - Search Results

1

Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.

Wildt M, Hesselstrand R, Akesson A, Scheja A. Wildt M, et al. Scand J Rheumatol. 2007 Nov-Dec;36(6):452-7. doi: 10.1080/03009740701483030. Scand J Rheumatol. 2007. PMID: 18092267

2

Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor.

Scheja A, Akesson A, Niewierowicz I, Wallin L, Wildt M, Wollheim FA. Scheja A, et al. Among authors: wildt m. Ann Rheum Dis. 1996 Jan;55(1):52-6. doi: 10.1136/ard.55.1.52. Ann Rheum Dis. 1996. PMID: 8572735 Free PMC article.

3

Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis.

Wildt M, Hesselstrand R, Scheja A, Akesson A. Wildt M, et al. Clin Exp Rheumatol. 1999 Mar-Apr;17(2):219-22. Clin Exp Rheumatol. 1999. PMID: 10342049

4

Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease.

Scheja A, Elborgh R, Wildt M. Scheja A, et al. Among authors: wildt m. J Rheumatol. 1999 Jun;26(6):1377-81. J Rheumatol. 1999. PMID: 10381059

5

Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement.

Scheja A, Wildt M, Wollheim FA, Akesson A, Saxne T. Scheja A, et al. Among authors: wildt m. Rheumatology (Oxford). 2000 Oct;39(10):1110-3. doi: 10.1093/rheumatology/39.10.1110. Rheumatology (Oxford). 2000. PMID: 11035131

6

Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).

Scheja A, Akesson A, Geborek P, Wildt M, Wollheim CB, Wollheim FA, Vischer UM. Scheja A, et al. Among authors: wildt m. Arthritis Res. 2001;3(3):178-82. doi: 10.1186/ar295. Epub 2001 Feb 19. Arthritis Res. 2001. PMID: 11299058 Free PMC article.

7

The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis.

Hesselstrand R, Westergren-Thorsson G, Scheja A, Wildt M, Akesson A. Hesselstrand R, et al. Among authors: wildt m. Clin Exp Rheumatol. 2002 May-Jun;20(3):301-8. Clin Exp Rheumatol. 2002. PMID: 12102465

8

Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis.

Akesson A, Hesselstrand R, Scheja A, Wildt M. Akesson A, et al. Among authors: wildt m. Ann Rheum Dis. 2004 Jul;63(7):791-6. doi: 10.1136/ard.2003.012146. Ann Rheum Dis. 2004. PMID: 15194573 Free PMC article.

9

Small intestinal manometry in patients with systemic sclerosis.

Sjölund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A. Sjölund K, et al. Among authors: wildt m. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1205-12. doi: 10.1097/00042737-200511000-00009. Eur J Gastroenterol Hepatol. 2005. PMID: 16215433

10

Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma.

Larsen K, Malmström J, Wildt M, Dahlqvist C, Hansson L, Marko-Varga G, Bjermer L, Scheja A, Westergren-Thorsson G. Larsen K, et al. Among authors: wildt m. Respir Res. 2006 Jan 23;7(1):11. doi: 10.1186/1465-9921-7-11. Respir Res. 2006. PMID: 16430780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters